Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 6
  • Start Date: March 2021
The Efficacy and Safety of Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 18
  • Start Date: May 16, 2019
Open Label Exploratory Phase 2a Trial to Investigate the Safety and Efficacy of IFX-1 in Treating Subjects With Pyoderma Gangrenosum (Optima)
Search for trials
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 8
  • Start Date: April 2016
Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
Showing 1-3 of 3